We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TTMI:NASDAQTTM Technologies, Inc. Analysis

Data as of 2026-05-06 - not real-time

$164.64

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

TTMI is trading at $164.64, comfortably above its 20‑day SMA of 135.55 and its 50‑day SMA of 113.55, confirming a strong bullish momentum. The 20‑day SMA also sits well above the 200‑day SMA of 77.73, underscoring a multi‑month uptrend. Momentum indicators are mixed: the MACD line (14.48) remains above its signal (11.94) signaling bullish pressure, while the RSI of 75.5 places the stock in overbought territory. Volume has been increasing, and the price is holding above the identified support at $105.05 with resistance near $180, giving ample room for further upside. Recent news shows a 12.2% intraday jump after an earnings beat and a 4.8% rise tied to easing geopolitical tensions, reflecting strong market enthusiasm. The Fear & Greed Index reads “Extreme Greed” at 90.29, indicating heightened investor optimism. However, the 30‑day volatility of 89.55% and a beta above 3 highlight susceptibility to sharp swings.
On the fundamentals side, TTMI delivered 30.4% revenue growth YoY and posted an EPS beat of $0.75 versus consensus $0.66, with forward EPS projected at $5.03. Margins remain modest (gross 21%, operating 8.6%, profit 6.3%) and free cash flow is negative $55 M, while debt‑to‑equity sits at 57%, suggesting a leveraged balance sheet. The trailing P/E of 89.5 dwarfs the industry average of 37.2, and the DCF fair value of $73.34 is far below the current price, signaling a potentially overvalued condition. Nevertheless, the forward P/E of 32.7 and an analyst consensus “strong buy” with a median target of $170 imply that upside of roughly 3% remains plausible. The company’s exposure to defense and aerospace contracts adds a layer of regulatory and geopolitical risk, but also offers a defensive revenue cushion. With high liquidity (average 10‑day volume ~2.9 M) and a market cap of $17 B, short‑term trading risks are mitigated despite the elevated volatility. Overall, the blend of robust growth drivers and stretched valuation calls for a cautious but optimistic stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI overbought indicating near‑term pullback
  • Strong recent earnings momentum
  • High volatility and beta may cause price swings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 30% YoY revenue growth
  • Forward P/E ~33 offering valuation compression
  • Analyst strong‑buy consensus with target $170

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Defense and aerospace contract exposure
  • Sustained multi‑year uptrend in moving averages
  • Industry tailwinds for PCB demand

Key Metrics & Analysis

Financial Health

Revenue Growth30.40%
Profit Margin6.29%
P/E Ratio89.5
ROE11.40%
ROA4.86%
Debt/Equity57.10
P/B Ratio9.7
Op. Cash Flow$324.3M
Free Cash Flow$-55001000
Industry P/E37.2

Technical Analysis

TrendBullish
RSI75.5
Support$105.05
Resistance$180.00
MA 20$135.55
MA 50$113.55
MA 200$77.73
MACDBullish
VolumeIncreasing
Fear & Greed Index90.29

Valuation

Fair Value$73.34
Target Price$170.00
Upside/Downside3.26%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta3.14
Volatility89.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.